• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下一代ProtEmbo脑栓塞保护系统在经导管主动脉瓣中瓣植入术中的首次人体应用。

First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic Protection System During Transcatheter Aortic Valve-in-valve Implantation.

作者信息

Jagielak Dariusz, Targonński Radoslaw, Ciećwierz Dariusz

机构信息

Department of Cardiac and Vascular Surgery, Medical University of Gdansk Gdansk, Poland.

First Department of Cardiology, Medical University of Gdansk Gdansk, Poland.

出版信息

Interv Cardiol. 2021 Feb 2;16(Suppl 1):1-4. doi: 10.15420/icr.2021.S1. eCollection 2021 Apr.

DOI:10.15420/icr.2021.S1
PMID:33786063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919677/
Abstract

Cerebral embolic protection (CEP) devices aim to reduce the risk of periprocedural cerebrovascular events during transcatheter aortic valve implantation (TAVI). Here, the authors describe the first-in-human experience with the ProtEmbo Cerebral Protection System (Protembis), a next-generation CEP device, during TAVI. This case is part of a larger European trial evaluating the safety and performance of this device. After deployment of the ProtEmbo in the aortic arch, a first transcatheter heart valve was implanted. Despite postdilatation, moderate to severe aortic regurgitation persisted. The operating team decided to perform a valve-in-valve procedure using a second transcatheter heart valve. The ProtEmbo demonstrated good coverage of all three head vessels and no interaction with TAVI catheters in the aortic arch throughout the entire procedure. No adverse events were observed during hospitalisation or follow-up, and there was a significant reduction in aortic regurgitation at follow-up echocardiography. Despite a challenging overall procedure with presumably high embolic burden, diffusion-weighted MRI at follow-up showed a low number (n=3) and volume (156 mm) of new hyperintense lesions. The first-in-human use of the ProtEmbo was safe and feasible, despite a challenging TAVI valve-in-valve procedure.

摘要

脑栓塞保护(CEP)装置旨在降低经导管主动脉瓣植入术(TAVI)期间围手术期脑血管事件的风险。在此,作者描述了在TAVI期间使用新一代CEP装置ProtEmbo脑保护系统(Protembis)的首例人体经验。该病例是一项评估该装置安全性和性能的大型欧洲试验的一部分。在主动脉弓中部署ProtEmbo后,植入了第一个经导管心脏瓣膜。尽管进行了后扩张,但中度至重度主动脉瓣反流仍然存在。手术团队决定使用第二个经导管心脏瓣膜进行瓣中瓣手术。在整个手术过程中,ProtEmbo对所有三根头臂血管均显示出良好的覆盖,且与主动脉弓中的TAVI导管无相互作用。住院期间或随访期间未观察到不良事件,随访超声心动图显示主动脉瓣反流显著减少。尽管整个手术具有挑战性且栓塞负荷可能较高,但随访时的扩散加权磁共振成像显示新的高强度病变数量较少(n=3)且体积较小(156立方毫米)。尽管TAVI瓣中瓣手术具有挑战性,但ProtEmbo的首例人体使用是安全可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e46/7919677/cb5a5ae33dde/icr-16-Supp1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e46/7919677/cb5a5ae33dde/icr-16-Supp1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e46/7919677/cb5a5ae33dde/icr-16-Supp1-g001.jpg

相似文献

1
First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic Protection System During Transcatheter Aortic Valve-in-valve Implantation.下一代ProtEmbo脑栓塞保护系统在经导管主动脉瓣中瓣植入术中的首次人体应用。
Interv Cardiol. 2021 Feb 2;16(Suppl 1):1-4. doi: 10.15420/icr.2021.S1. eCollection 2021 Apr.
2
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial.新型经导管主动脉瓣植入术脑保护装置的安全性和性能:PROTEMBO C 试验。
EuroIntervention. 2022 Sep 20;18(7):590-597. doi: 10.4244/EIJ-D-22-00238.
3
First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.首例新型栓塞保护装置在经导管主动脉瓣植入术中的应用。
EuroIntervention. 2012 May 15;8(1):43-50. doi: 10.4244/EIJV8I1A8.
4
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者中脑保护装置对脑损伤的影响:CLEAN-TAVI 随机临床试验。
JAMA. 2016 Aug 9;316(6):592-601. doi: 10.1001/jama.2016.10302.
5
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.经导管主动脉瓣介入治疗中新型栓塞转向装置的首例人体应用经验。
EuroIntervention. 2012 May 15;8(1):51-6. doi: 10.4244/EIJV8I1A9.
6
TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.用于经导管主动脉瓣置换术中脑保护的TriGuard HDH栓子偏转装置。
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):470-477. doi: 10.1002/ccd.26566. Epub 2016 Apr 28.
7
Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.探索接受经导管主动脉瓣置换术与外科主动脉瓣置换术的主动脉瓣狭窄患者术后中风发生率的差异。
Cureus. 2018 Apr 17;10(4):e2494. doi: 10.7759/cureus.2494.
8
Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation Using the Sentinel Cerebral Protection System: A Systematic Review and Meta-Analysis.使用Sentinel脑保护系统在经导管主动脉瓣植入术中进行脑栓塞保护:一项系统评价和荟萃分析。
Cardiol Ther. 2024 Jun;13(2):299-314. doi: 10.1007/s40119-024-00359-4. Epub 2024 Feb 10.
9
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.首例人体研究评估 Emblok 栓塞保护系统在经导管主动脉瓣置换术中的应用。
JACC Cardiovasc Interv. 2020 Apr 13;13(7):860-868. doi: 10.1016/j.jcin.2019.11.017.
10
"Tailor-made" Total Cerebral Protection during Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术中的“定制化”全脑保护。
Neurol Med Chir (Tokyo). 2021 Dec 15;61(12):741-749. doi: 10.2176/nmc.oa.2021-0005. Epub 2021 Oct 7.

引用本文的文献

1
Embolic Protection Devices in Transcatheter Aortic Valve Implantation: A Narrative Review of Current Evidence.经导管主动脉瓣植入术中的栓塞保护装置:当前证据的叙述性综述
J Clin Med. 2025 Jun 10;14(12):4098. doi: 10.3390/jcm14124098.
2
Fighting Cardiac Thromboembolism during Transcatheter Procedures: An Update on the Use of Cerebral Protection Devices in Cath Labs and EP Labs.经导管手术期间对抗心脏血栓栓塞:导管实验室和心脏电生理实验室中脑保护装置使用的最新进展
Life (Basel). 2023 Aug 28;13(9):1819. doi: 10.3390/life13091819.
3
Periprocedural Strategies for Stroke Prevention in Patients Undergoing Transcatheter Aortic Valve Implantation.

本文引用的文献

1
Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis.经导管主动脉瓣置换术期间的脑栓塞保护:一项临床事件荟萃分析。
J Am Coll Cardiol. 2017 Jan 31;69(4):465-466. doi: 10.1016/j.jacc.2016.12.002.
2
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中的脑栓塞保护。
J Am Coll Cardiol. 2017 Jan 31;69(4):367-377. doi: 10.1016/j.jacc.2016.10.023. Epub 2016 Nov 1.
3
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
经导管主动脉瓣植入术患者预防卒中的围手术期策略
Front Cardiovasc Med. 2022 Apr 26;9:892956. doi: 10.3389/fcvm.2022.892956. eCollection 2022.
经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者中脑保护装置对脑损伤的影响:CLEAN-TAVI 随机临床试验。
JAMA. 2016 Aug 9;316(6):592-601. doi: 10.1001/jama.2016.10302.
4
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.经导管主动脉瓣植入术中TriGuard™ HDH栓塞偏折装置的前瞻性随机评估:DEFLECT III试验结果
Eur Heart J. 2015 Aug 14;36(31):2070-2078. doi: 10.1093/eurheartj/ehv191. Epub 2015 May 19.